TITLE

Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

AUTHOR(S)
Lowe, Lynn P.; Metzger, Boyd E.; Dyer, Alan R.; Lowe, Julia; McCance, David R.; Lappin, Terence R. J.; Trimble, Elisabeth R.; Coustan, Donald R.; Hadden, David R.; Hod, Moshe; Oats, Jeremy J. N.; Persson, Bengt
PUB. DATE
March 2012
SOURCE
Diabetes Care;Mar2012, Vol. 35 Issue 3, p574
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE--To compare associations of maternal glucose and A1C with adverse outcomes in the multinational Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and determine, based on those comparisons, if A1C measurement can provide an alternative to an oral glucose tolerance test (OGTT) in pregnant women. RESEARCH DESIGN AND METHODS--Eligible pregnant women underwent a 75-g OGTT at 24-32 weeks' gestation. A sample for A1Cwas also collected. Neonatal anthropometrics and cord serum C-peptide were measured. Associations with outcomes were assessed using multiple logistic regression with adjustment for potential confounders. RESULTS--Among 23,316 HAPO Study participants with glucose levels blinded to caregivers, 21,064 had a nonvariant A1C result. The mean ± SD A1C was 4.79±0.40%. Associations were significantly stronger with glucose measures than with A1C for birth weight, sum of skinfolds, and percent body fat >90th percentile and for fasting and 1-h glucose for cord C-peptide (all P< 0.01). For example, in fully adjusted models, odds ratios (ORs) for birth weight >90th percentile for each measure higher by 1 SD were 1.39, 1.45, and 1.38, respectively, for fasting, 1-, and 2-h plasma glucose and 1.15 for A1C. ORs for cord C-peptide >90th percentile were 1.56, 1.45, and 1.35 for glucose, respectively, and 1.32 for A1C. ORs were similar for glucose and A1C for primary cesarean section, preeclampsia, and preterm delivery. CONCLUSIONS--On the basis of associations with adverse outcomes, these findings suggest that A1C measurement is not a useful alternative to an OGTT in pregnant women.
ACCESSION #
72447875

 

Related Articles

  • The relationship between glycated hemoglobin and blood glucose levels of 75 and 100 gram oral glucose tolerance test during gestational diabetes diagnosis. Mert, Meral; Purcu, Serhat; Soyluk, Ozlem; Okuturlar, Yildiz; Karakaya, Pinar; Tamer, Gonca; Adas, Mine; Ekin, Murat; Hatipoglu, Sami; Sari Ure, Oznur; Harmankaya, Ozlem; Kumbasar, Abdulbaki // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 8, p13335 

    Objective: The diagnosis of gestational diabetes mellitus (GDM) is an important issue in terms of prevention of maternal and fetal complications. In our study we aimed to evaluate the relation of HbA1c and blood glucose levels of 75 and 50-100 gram oral glucose tolerance test (OGTT) in pregnant...

  • Correlation of Glycosylated Hemoglobin and Glucose Response to Oral Glucose Tolerance Test. Kokkoris, Panagiotis; Chantziara, Clio; Toloumis, George // Diabetes;Jun2007 Supplement 1, Vol. 56, pA254 

    Glycosylated hemoglobin (HbA1c) is a reliable index of glycemic control in known diabetic patients; but its role is not very clear in riot known diabetics. The aim of the study is to find if there is any correlation between HbA1c and glucose response at the oral glucose tolerance test (OGTT) in...

  • An observational study comparing 2-hour 75-g oral glucose tolerance with fasting plasma glucose in pregnant women: both poorly predictive of birth weight. Ouzilleau, Christian; Roy, Marie-Andrée; Leblanc, Louiselle; Carpentier, André; Maheux, Pierre // CMAJ: Canadian Medical Association Journal;2/18/2003, Vol. 168 Issue 4, p403 

    Background The definition and treatment of glucose intolerance during pregnancy are matters of intense controversy. Our goal was to examine the value of the 75-g oral glucose tolerance test (OGTT) in terms of its ability to predict birth weight percentile in a group of women with singleton...

  • The Role of Untimed Blood Glucose in Screening for Gestational Diabetes Mellitus in a High Prevalent Diabetic Population. Cuschieri, Sarah; Craus, Johann; Savona-Ventura, Charles // Scientifica;2/21/2016, p1 

    Global prevalence increase of diabetes type 2 and gestational diabetes (GDM) has led to increased awareness and screening of pregnant women for GDM. Ideally screening for GDM should be done by an oral glucose tolerance test (oGTT), which is laborious and time consuming. A randomized glucose test...

  • The Relationship Between β-Cell Function and Glycated Hemoglobin. KANAT, MUSTAFA; WINNIER, DIEDRE; NORTON, LUKE; ARAR, NAZIK; JENKINSON, CHRIS; DEFRONZO, RALPH A.; ABDUL-GHANI, MUTIAMMAD A. // Diabetes Care;Apr2011, Vol. 34 Issue 4, p1006 

    OBJECTIVE--The study objective was to assess the relationship between β-cell function and HbA1c. RESEARCH DESIGN AND METHODS--A total of 522 Mexican American subjects participated in this study. Each subject received a 75-g oral glucose tolerance test (OGTT) after a 10- to 12-h overnight...

  • UP780, a Chromone-Enriched Aloe Composition Improves Insulin Sensitivity. Yimam, Mesfin; Zhao, Jifu; Corneliusen, Brandon; Pantier, Mandee; Brownell, Lidia Alfaro; Jia, Qi // Metabolic Syndrome & Related Disorders;Aug2013, Vol. 11 Issue 4, p267 

    Background: Diabetic individuals experience elevated fasting glucose, glycosylated hemoglobin (HbA1c), and plasma insulin and impaired glucose tolerance. Adiponectin is a hormone inversely correlated with insulin resistance. Here we describe the activity of aloesin, an aloe chromone that...

  • Hemoglobin A1C for Diagnosis of Diabetes.  // RN;Jul2009, Vol. 72 Issue 7, p12 

    The article reports that Members of the American Diabetes Association, the International Diabetes Federation, and the European Association for the Study of Diabetes have determined that hemoglobin A1C (HbA1c) assays should be the method of diagnosis of type 2 diabetes. The test would replace...

  • A1C assay emerges as the new standard diagnostic test. Beer, Karen; Zarbock, Sarah // JAAPA: Journal of the American Academy of Physician Assistants (;Feb2010, Vol. 23 Issue 2, p50 

    The article offers information on the use of glycosylated hemoglobin (A1C) assay as the diagnostic test for diabetes. The test is expected to replace traditional fasting plasma glucose and oral glucose tolerance tests. The advantages of A1C includes, it measures average glucose levels for over...

  • Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups. Soliman, Ashraf; DeSanctis, Vincenzo; Yassin, Mohamed; Elalaily, Rania; Eldarsy, Nagwa E. // Indian Journal of Endocrinology & Metabolism;May/Jun2014, Vol. 18 Issue 3, p274 

    Continuous glucose monitoring (CGM) systems are an emerging technology that allows frequent glucose measurements to monitor glucose trends in real time. Their use as a diagnostic tool is still developing and appears to be promising. Combining intermittent glucose self-monitoring (SGM) and CGM...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics